NBTXR3 improves the efficacy of immunoradiotherapy combining nonfucosylated anti-CTLA4 in an anti-PD1 resistant lung cancer model

por Hu, Yun, Paris, Sébastien, Bertolet, Genevieve, Barsoumian, Hampartsoum B., Wang, Qi, Da Silva, Jordan, Patel, Nalini B., Nguyen, Nguyen, Doss, Denaha J., Huang, Ailing, Hsu, Ethan, Leyton, Claudia S. Kettlun, Voss, Tiffany A., Masrorpour, Fatemeh, Leuschner, Carola, Pietz, Jordan T., Puebla-Osorio, Nahum, Gandhi, Saumil, Nguyen, Quynh-Nhu, Wang, Jing, Cortez, Maria Angelica, Welsh, James W.
Publicado 2022

Nanoparticle-enhanced proton beam immunoradiotherapy drives immune activation and durable tumor rejection

por Hu, Yun, Paris, Sébastien, Sahoo, Narayan, Bertolet, Genevieve, Wang, Qi, Wang, Qianxia, Barsoumian, Hampartsoum B., Da Silva, Jordan, Huang, Ailing, Doss, Denaha J., Pollock, David P., Hsu, Ethan, Selene, Nanez, Leyton, Claudia S. Kettlun, Voss, Tiffany A., Masrorpour, Fatemeh, Ganjoo, Shonik, Leuschner, Carola, Pietz, Jordan T., Puebla-Osorio, Nahum, Gandhi, Saumil, Nguyen, Quynh-Nhu, Wang, Jing, Cortez, Maria Angelica, Welsh, James W.
Publicado 2023